The binding affinity of this conjugate to CD44 antigen was improved by multivalent binding of Apt-Lip, compared to that of the aptamer alone; consequently, Apt-Lip delivered more Dox to the target CD44+ cancer cells. The gene discussed is CD44; the disease is cancer.